Lotus Pharmaceuticals, Inc. (LTUS)

OTCMKTS · Delayed Price · Currency is USD

0.0041

-0.0013 (-24.76%)

At close: Feb 25, 2026

16.09% (1Y)

Market Cap	10.74M
Revenue (ttm)	71.39M
Net Income (ttm)	1.72M
Shares Out	2.64B
EPS (ttm)	0.06
PE Ratio	0.07
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,660
Average Volume	27,859
Open	0.0041
Previous Close	0.0054
Day's Range	0.0041 - 0.0041
52-Week Range	0.0025 - 0.0111
Beta	-1.96
RSI	49.56
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California. [Read more]

Industry Shell Companies

Sector Financials

CEO Zhong Yi Liu

Employees 383

Stock Exchange OTCMKTS

Ticker Symbol LTUS

Full Company Profile

Financial Performance

In 2010, Lotus Pharmaceuticals's revenue was $72.70 million, an increase of 28.71% compared to the previous year's $56.48 million. Earnings were $14.42 million, a decrease of -12.22%.

News

There is no news available yet.